JAX Guide: Assessing Antibody Pharmacokinetics Using the JAX FcRn Platform
In this guide, we will discuss several challenges in developing antibody-based therapeutics,
including assessing pharmacokinetic characteristics, selecting efficacious variants, and
determining the appropriate dose. We'll also provide details on how the JAX Therapeutic Evaluation Services can give fast and cost-effective analyses of IgG-based therapies.